Product Name: LITAF antibody [AT1F9]
Applications: ELISA, WB
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration)
Purification: By protein-G affinity chromatography
Full Name: lipopolysaccharide-induced TNF factor
Background: Lipopolysaccharide-induced tumor necrosis factor-alpha factor(LITAF) mediates the expression of inflammatory cytokines such as TNF-alpha in Lipopolysaccharide-induced processes. LITAF binds to STAT6B, a member of the STAT6 family forming a complex on the TNF-alpha promoter that modulates TNF activity. High levels of expression of LITAF mRNA have been observed predominantly in the placenta, peripheral blood leukocytes, lymph nodes and spleen.
Synonyms: lipopolysaccharideinduced TNF factor, lipopolysaccharide-induced TNF factor, SIMPLE, LITAF, FLJ38636, TP53I7, PIG7
Cellular Localization: Associated with membranes of lysosomes.
CAS NO: 59-67-6
Product: Cardiogreen
Host: Mouse
Clonality: Monoclonal
Isotype: IgG1
Immunogen: Recombinant human LITAF (1-161aa) purified from E. coli
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: Supplied in Phosphate-Buffered Saline (pH 7.4) with 0.1% Sodium Azide.
Storage Instruction: Can be stored at +4C. For long term storage, aliquot and store at -20C. Avoid repeated freezing and thawing cycles.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity:
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/15988529?dopt=Abstract
